Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00512 GRAND PHARMA
RT Nominal up6.270 +1.030 (+19.656%)
Latest  |  Final  |  Interim
2024/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
Turnover11,644,89210.592%10,529,5909,562,2858,597,9756,352,919
Cost of Sales(4,906,576)22.495%(4,005,524)(3,610,806)(3,350,737)(2,317,725)

Gross Profit6,738,3163.284%6,524,0665,951,4795,247,2384,035,194
2024/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
Change in FV & Impairment on Inv. Prop.------------
Change in FV & Impairment on Others599,4723094.969%18,763(91,345)(8,350)253,604
Profit / (Loss) on Disposal------------
Other Non-operating Items(73,378)25.082%(58,664)23,017484,495--
Share of Results of Asso. & JCEs148,720--(25,008)(43,786)113,86261,979

Profit / (Loss) before Taxation2,852,36321.678%2,344,1972,516,8932,785,8322,073,583
Taxation(386,304)-13.917%(448,755)(418,642)(380,800)(292,374)
Profit / (Loss) from Discontinued Operations------------
Non-controlling Interests2,316--(15,444)(18,832)(2,469)11,452
Others------------

Profit / (Loss) Attributable to Shareholders2,468,37531.297%1,879,9982,079,4192,402,5631,792,661
2024/12 - Final
HKD(K$)
%Chg
(Compare to Final)
2023/12
HKD(K$)
2022/12
HKD(K$)
2021/12
HKD(K$)
2020/12
HKD(K$)
Net Finance Costs / (Income)180,242-8.692%197,400117,68718,01197,375
Depreciation & Amortisation503,74828.438%392,210394,912339,519287,061
Directors' Emoluments----8,9886,3574,5542,434
2024/12 - Final %Chg
(Compare to Final)
2023/12 2022/12 2021/12 2020/12
Auditor's Opinion StatusUnqualified--UnqualifiedUnqualifiedUnqualifiedUnqualified
Market Valuation Indicators
2024/12 - Final %Chg
(Compare to Final)
2023/12 2022/12 2021/12 2020/12
EPS (cts)70.49031.511%53.60058.70067.72052.030
DPS (cts)26.000--26.00014.00011.00011.000
Dividend Payout Ratio (%)36.885%--48.507%23.850%16.243%21.142%
Cash flow per share ($)----0.6910.5200.5650.423
NBV per share ($)4.641--4.2703.9843.7733.166
Remarks:  Real time quote last updated: 13/03/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service.
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K$)HKD 1,557,945
%Change51.352%
EPS / (LPS)HKD 0.444
NBV Per Share ($)HKD 4.428
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.